Know Cancer

or
forgot password

    • cancer clinical trials in saginaw, MI

    • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Melanoma (Skin)
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Prostate Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Head and Neck Cancer, Oral Complications
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Seton Cancer Institute - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Lung Cancer
    Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Esophageal Cancer, Gastric Cancer
    Anastrozole & ZD1839 Compared With Fulvestrant & ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
    Seton Cancer Institute - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Lung Cancer
    Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Endometrial Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Creatine in Treating Patients With Cancer-Associated Weight Loss
    Seton Cancer Institute - Saginaw
    Saginaw, Michigan 48601
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Prostate Cancer
    Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Mantle Cell Lymphoma
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
    Seton Cancer Institute - Saginaw
    Saginaw, Michigan 48601
    Chronic Myeloproliferative Disorders
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Seton Cancer Institute - Saginaw
    Saginaw, Michigan 48601
    Fallopian Tube Cancer, Ovarian Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Head and Neck Cancer
    Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Lung Cancer, Pain, Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Lung Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Esophageal Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer, Metastatic Cancer
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Anal Cancer
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Lung Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Endometrial Cancer
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Lung Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer